Carregant...
Genomic profiling for copy number changes in plasma of ovarian cancer patients – a new era for cancer diagnostics?
A blood test that can detect human malignancy with high clinical sensitivity and specificity is highly desirable. To achieve this, a tumor marker is needed that correlates with tumor burden and that can be measured with high analytical sensitivity and specificity. Over the past decades, a number of...
Guardat en:
| Publicat a: | BMC Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5112646/ https://ncbi.nlm.nih.gov/pubmed/27852253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-016-0741-0 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|